Kadcyla 160mg 1 Injection

Patent medicine name

Kadcyla 160mg 1 Injection

Manufacturer

Roche

Specification

Physical Form: Injection, Quantity: 1/box, Storage: Room Temperature(2-8°C)

Price

$1800-2000

Generic medicine name & Manufacturer

Specification

Price

Composition

Trastuzumab

Use

Breast cancer

Medicince introduction including background, function, caution, etc.

Indication
Kadcyla 160 mg Injection is used in the treatment of breast cancer. It is used to treat certain types of breast cancer (human epidermal growth factor receptor 2, HER-2) which have spread to other organs and have not responded to other cancer medicines.
Side Effects
Tiredness, Nausea, Musculoskeletal (bone, muscle or joint) pain, Bleeding, Low blood platelets, Headache, Liver disorder, Constipation, Nosebleeds
Mechanism Of Action
Kadcyla 160 mg Injection is an anti-cancer medicine. It binds to HER2 receptors on breast cancer cells and flags the cancer cells for destruction by the body’s immune system. It also goes into the cancer cells to release a chemotherapy medicine (emtansine) and stop them from growing and dividing.

Use in Other language

Picture